Pediatrix Medical
307 hedge funds and large institutions have $2.76B invested in Pediatrix Medical in 2018 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 89 increasing their positions, 124 reducing their positions, and 65 closing their positions.
2% more call options, than puts
Call options by funds: $769K | Put options by funds: $751K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.47% less ownership
Funds ownership: 94.89% → 93.42% (-1.5%)
4% less funds holding
Funds holding: 320 → 307 (-13)
20% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 65
28% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 124
33% less capital invested
Capital invested by funds: $4.14B → $2.76B (-$1.38B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$29.8M |
| 2 |
Lazard Asset Management
New York
|
+$22.3M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$18.8M |
| 4 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
+$18.1M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$15.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$68.6M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$66.7M |
| 3 |
Millennium Management
New York
|
-$39.7M |
| 4 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$37.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$36.8M |
MD Hedge Fund Activity: Q4 2018 in Review
307 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2018, worth a combined $2.76B — down 33% from $4.14B a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of MD and 52 opened new positions — a net loss of 13 holders — while 124 trimmed existing stakes and 89 added.
The largest buyer was Ardevora Asset Management, adding an estimated $29.8M. The largest seller was OrbiMed, exiting entirely with an estimated $68.6M sold.
- 307 institutional investors held Pediatrix Medical (MD) as of Q4 2018, down from 320 in Q3 2018.
- Funds reported $2.76B of Pediatrix Medical stock for Q4 2018, down 33% quarter-over-quarter.
- 52 funds opened new Pediatrix Medical positions in Q4 2018 and 65 closed out, a net change of -13 holders.
- The largest Pediatrix Medical buyer in Q4 2018 was Ardevora Asset Management, an estimated $29.8M added.
- The largest Pediatrix Medical seller in Q4 2018 was OrbiMed, an estimated $68.6M sold.
Based on aggregated 13F filings for Q4 2018.